相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662
Serge Ducommun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Repurposing of Metformin and Aspirin by Targeting AMPK-mTOR and Inflammation for Pancreatic Cancer Prevention and Treatment
Wen Yue et al.
CANCER PREVENTION RESEARCH (2014)
Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
Sara Gandini et al.
CANCER PREVENTION RESEARCH (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Small Molecule Drug A-769662 and AMP Synergistically Activate Naive AMPK Independent of Upstream Kinase Signaling
John W. Scott et al.
CHEMISTRY & BIOLOGY (2014)
Metformin Does Not Affect Cancer Risk: A Cohort Study in the UK Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
Konstantinos K. Tsilidis et al.
DIABETES CARE (2014)
The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation
Ming Yan et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation
Ge Zhou et al.
MOLECULAR CELL (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
Xiaona Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: Dependence on glucose concentration and role of AMPK
James Sinnett-Smith et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
AMPK: A Contextual Oncogene or Tumor Suppressor?
Jiyong Liang et al.
CANCER RESEARCH (2013)
AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation
Graeme J. Gowans et al.
CELL METABOLISM (2013)
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Brandon Faubert et al.
CELL METABOLISM (2013)
Metformin Inhibits the Growth of Human Pancreatic Cancer Xenografts
Krisztina Kisfalvi et al.
PANCREAS (2013)
Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
Heloisa P. Soares et al.
PLOS ONE (2013)
Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells
Lihong Wang et al.
PLOS ONE (2013)
MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth
Ting-Fang Lo et al.
PLOS ONE (2013)
Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
Navid Sadeghi et al.
CLINICAL CANCER RESEARCH (2012)
Sustained Antidiabetic Effects of a Berberine-Containing Chinese Herbal Medicine Through Regulation of Hepatic Gene Expression
Hai-Lu Zhao et al.
DIABETES (2012)
Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells
Yu Wang et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2012)
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Sang-Min Jeon et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Berberine Induces Caspase-Independent Cell Death in Colon Tumor Cells through Activation of Apoptosis-Inducing Factor
Lihong Wang et al.
PLOS ONE (2012)
Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells
Sutapa Mahata et al.
MOLECULAR CANCER (2011)
Mitochondrial Dysfunction Links Ceramide Activated HRK Expression and Cell Death
Farhan Rizvi et al.
PLOS ONE (2011)
Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
Xuan Xia et al.
PLOS ONE (2011)
Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice
Weidong Xie et al.
PLOS ONE (2011)
AMPK Is a Direct Adenylate Charge-Regulated Protein Kinase
Jonathan S. Oakhill et al.
SCIENCE (2011)
Hepatoprotective activity of berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl4-intoxicated mice
Robert Domitrovic et al.
TOXICOLOGY (2011)
Crosstalk between insulin receptor and G protein-coupled receptor signaling systems leads to Ca2+ oscillations in pancreatic cancer PANC-1 cells
Steven H. Young et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Simon A. Hawley et al.
CELL METABOLISM (2010)
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
Adem Kalender et al.
CELL METABOLISM (2010)
Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
Enrique Rozengurt et al.
CLINICAL CANCER RESEARCH (2010)
Acute toxicity of berberine and its correlation with the blood concentration in mice
Michael M. Kheir et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
Issam Ben Sahra et al.
MOLECULAR CANCER THERAPEUTICS (2010)
AMP-Activated Protein Kinase Inhibits IGF-I Signaling and Protein Synthesis in Vascular Smooth Muscle Cells via Stimulation of Insulin Receptor Substrate 1 S794 and Tuberous Sclerosis 2 S1345 Phosphorylation
Junyu Ning et al.
MOLECULAR ENDOCRINOLOGY (2010)
Berberine Inhibits Cell Growth and Mediates Caspase-Independent Cell Death in Human Pancreatic Cancer Cells
Lina Pinto-Garcia et al.
PLANTA MEDICA (2010)
Phenotype and Genotype of Pancreatic Cancer Cell Lines
Emily L. Deer et al.
PANCREAS (2010)
Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
Krisztina Kisfalvi et al.
CANCER RESEARCH (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols
Jin-Taek Hwang et al.
NEW BIOTECHNOLOGY (2009)
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Pamela J. Goodwin et al.
CLINICAL BREAST CANCER (2008)
Metabolic syndrome and cancer risk
Antonio Russo et al.
EUROPEAN JOURNAL OF CANCER (2008)
Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine
Yifei Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Mitogenic signaling pathways induced by G protein-coupled receptors
Enrique Rozengurt
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
Gillian K. Reeves et al.
BRITISH MEDICAL JOURNAL (2007)
Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family
Matthew J. Sanders et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Prediagnostic plasma c-pepticle and pancreatic cancer risk in men and women
Dominique S. Michaud et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study
M. C. Perrin et al.
BMC MEDICINE (2007)
Anthropometry and pancreatic cancer risk: An illustration of the importance of microscopic verification
Bas A. J. Verhage et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Insulin potentiates Ca2+ signaling and phosphatidylinositol 4,5-bisphosphate hydrolysis induced by Gq protein-coupled receptor agonists through an mTOR-dependent pathway
Krisztina Kisfalvi et al.
ENDOCRINOLOGY (2007)
Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794
Alexandros Tzatsos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Antihypertensives as novel antineoplastics: Angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma
Hwyda A. Arafat et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
G-protein-coupled receptors and cancer
Robert T. Dorsam et al.
NATURE REVIEWS CANCER (2007)
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth
Ken Inoki et al.
CELL (2006)
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
Yun S. Lee et al.
DIABETES (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells
SK Mantena et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers
RZ Stolzenberg-Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1 D-Trp5,7,9,Leu11]SP:: A dual inhibitor of growth and angiogenesis in pancreatic cancer
S Guha et al.
CANCER RESEARCH (2005)
Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells
K Kisfalvi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Fasting serum glucose level and cancer risk in Korean men and women
SH Jee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy
B Berker et al.
GYNECOLOGICAL ENDOCRINOLOGY (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Neuropeptides as growth factors for normal and cancerous cells
E Rozengurt
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Autocrine and paracrine signaling through neuropeptide receptors in human cancer
LE Heasley
ONCOGENE (2001)
Gastrin, CCK, signaling, and cancer
E Rozengurt et al.
ANNUAL REVIEW OF PHYSIOLOGY (2001)
[D-Arg1,D-Trp5,7,9,Leu11]substance P inhibits bombesin-induced mitogenic signal transduction mediated by both Gq and G12 in Swiss 3T3 cells
J Sinnett-Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
